Cargando…
Therapeutic Potential of Alpha-1 Antitrypsin in Type 1 and Type 2 Diabetes Mellitus
Alpha-1 antitrypsin (AAT) has established anti-inflammatory and immunomodulatory effects in chronic obstructive pulmonary disease but there is increasing evidence of its role in other inflammatory and immune-mediated conditions, like diabetes mellitus (DM). AAT activity is altered in both developing...
Autores principales: | Park, Sangmi S., Rodriguez Ortega, Romy, Agudelo, Christina W., Perez Perez, Jessica, Perez Gandara, Brais, Garcia-Arcos, Itsaso, McCarthy, Cormac, Geraghty, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073794/ https://www.ncbi.nlm.nih.gov/pubmed/33923873 http://dx.doi.org/10.3390/medicina57040397 |
Ejemplares similares
-
Mechanisms Linking COPD to Type 1 and 2 Diabetes Mellitus: Is There a Relationship between Diabetes and COPD?
por: Park, Sangmi S., et al.
Publicado: (2022) -
Type 1 diabetes contributes to combined pulmonary fibrosis and emphysema in male alpha 1 antitrypsin deficient mice
por: Park, Sangmi S., et al.
Publicado: (2023) -
Clarifying the relationship between pulmonary langerhans cell histiocytosis and Alpha 1 antitrypsin deficiency
por: McCarthy, Cormac, et al.
Publicado: (2021) -
A Review of Alpha-1 Antitrypsin Binding Partners for Immune Regulation and Potential Therapeutic Application
por: O’Brien, Michael E., et al.
Publicado: (2022) -
Pulmonary Function and Respiratory Diseases in Different Genotypes of Alpha-1 Antitrypsin Deficiency
por: María Hernández Pérez, José, et al.
Publicado: (2022)